Cilostazol - 0093-2064-50 - (Cilostazol)

Alphabetical Index


Drug Information of Cilostazol

Product NDC: 0093-2064
Proprietary Name: Cilostazol
Non Proprietary Name: Cilostazol
Active Ingredient(s): 100    mg/1 & nbsp;   Cilostazol
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Cilostazol

Product NDC: 0093-2064
Labeler Name: Teva Pharmaceuticals USA Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077027
Marketing Category: ANDA
Start Marketing Date: 20121024

Package Information of Cilostazol

Package NDC: 0093-2064-50
Package Description: 5000 TABLET in 1 BOTTLE (0093-2064-50)

NDC Information of Cilostazol

NDC Code 0093-2064-50
Proprietary Name Cilostazol
Package Description 5000 TABLET in 1 BOTTLE (0093-2064-50)
Product NDC 0093-2064
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Cilostazol
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20121024
Marketing Category Name ANDA
Labeler Name Teva Pharmaceuticals USA Inc
Substance Name CILOSTAZOL
Strength Number 100
Strength Unit mg/1
Pharmaceutical Classes Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]

Complete Information of Cilostazol


General Information